Past Webinar : On Demand45 min recordingRecorded July 2026
Why Is eConsent Adoption a Challenge? Your Questions Answered (Part 2)
This is the follow up to our first eConsent fireside chat. In Part 2, Curebase CEO Storm Stillman is joined by site leader Gloria Carlbert, consultant Doug Bain, and industry veteran Chris Bowen to work through the audience questions we did not have time for in Part 1. Tablets versus software, IRB workflow gaps, signature UX, and where AI is finally starting to move the needle on adoption.
Speakers
What you will hear
- Tablet versus software: whether site resistance is really a device problem or a user experience problem
- The IRB, sponsor, and site handoff that leaves sites falling back to paper mid study
- Why site owned eConsent is gaining traction, and where sponsor supplied tools break down
- Signature UX, dynamic forms, and designing for older or less tech fluent participants
- Where AI is starting to remove real barriers: auto generated consent metadata, videos, and translations
- What would actually push the industry off paper: incentives, regulator credit, and integrated platforms
Who this is for
Clinical operations, study start up, and site engagement leaders at sponsors and CROs, plus site directors and coordinators evaluating whether eConsent is worth the change management.
Want to see Curebase eConsent in action?
Talk to our team about how Curebase eConsent is designed for site adoption from day one.
